Follow-up of 68 children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Relevance of genotype for management

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 6, 2003, Pages 2624-2633

  Pinto, G ^a   Tardy, V ^c   Trivin, C ^a   Thalassinos, C ^a   Lortat Jacob, S ^b   Nihoul Fekete C ^b   Morel, Y ^c   Brauner, R ^b,d  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL DEBROUSSE   (France)

^d NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYPROGESTERONE; STEROID 21 MONOOXYGENASE; TESTOSTERONE;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; BODY HEIGHT; CHILD; CLINICAL EXAMINATION; CLINICAL FEATURE; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; GENETIC CORRELATION; GENOTYPE PHENOTYPE CORRELATION; HORMONE DETERMINATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NEWBORN; NEWBORN SCREENING; PRIORITY JOURNAL; SALT LOSING NEPHRITIS; STEROID 21 MONOOXYGENASE DEFICIENCY; VIRILIZATION;

EID: 0038644495     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021433     Document Type: Article

References (45)

1. Miller WL 1994 Genetics, diagnosis and management of 21-hydroxylase deficiency. J Clin Endocrinol Metab 78:241-246
2. White PC, Speiser PW 2000 Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 21:245-291
3. Pang SY, Wallace MA, Hofman L, Thuline HC, Dorche C, Lyon IC, Dobbins RH, Kling S, Fujieda K, Suwa S 1998 Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 81:866-874
4. Speiser PW, Dupont B, Rubinstein P, Piazza A, Kastelan A, New MI 1985 High frequency of non-classical steroid 21-hydroxylase deficiency. Am J Hum Genet 37:650-667
5. Zerah M, Ueshiba H, Wood E, Speiser PW, Crawford C, McDonald T, Pareira J, Gruen D, New MI 1990 Prevalence of nonclassical steroid 21-hydroxylase deficiency based on a morning salivary 17-hydroxyprogesterone screening test: a small study. J Clin Endocrinol Metab 70:1662-1667
6. Morel Y, Miller WL 1991 Clinical and molecular genefics of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Adv Hum Genet 20:1-68
7. Wedell A, Thilen A, Ritzen EM, Stengler B, Luthman H 1994 Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation. J Clin Endocrinol Metab 78:1145-1152
8. Wilson R, Mercado A, Cheng K, New MI 1995 Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. J Clin Endocrinol Metab 80:2322-2329
9. Witchel SF, Bhamidipati DK, Hoffman EP, Cohen JB 1996 Phenotypic heterogeneity associated with the splicing mutation in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 81:4081-4088
10. Jääskeläinen J, Levo A, Voutilainen R, Partanen J 1997 Population-wide evaluation of disease manifestation in relation to molecular genotype in steroid 21-hydroxylase (CYP21) deficiency: good correlation in a well defined population. J Clin Endocrinol Metab 82:3293-3297
11. Krone N, Braun A, Roscher AA, Knorr D, Schwarz HP 2000 Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from Southern Germany. J Clin Endocrinol Metab 85:1059-1065
12. Deneux C, Tardy V, Dib A, Mornet E, Billaud L, Charron D, Morel Y, Kuttenn F 2001 Phenotype-genotype correlation in 56 women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 86:207-213
13. Dracopoulou-Vabouli M, Maniati-Christidi M, Dacou-Voutetakis C 2001 The spectrum of molecular defects of the CYP21 gene in the Hellenic population: variable concordance between genotype and phenotype in the different forms of congenital adrenal hyperplasia. J Clin Endocrinol Metab 86:2845-2848
14. Prader A, Gurtner HP 1955 Das Syndrom des Pseudothermaphroditismus masculinus bei kongenitaler Nebennierenrindenhyperplasie ohne Androgenüberproduktion (adrenaler Pseudohermaphroditismus masculinus). Helv Paediatr Acta 10:397-411
15. Josso N, Fortier-Beaulieu M, Fauré C 1969 Genitography in intersexual states. A review of 86 cases with new criteria for the study of the uro-genital sinus. Acta Endocrinol (Copenh) 62:165-180
16. Sempe M, Pedron G, Roy MP 1979 Auxologie, méthodes et séquences. Paris: Théraplix
17. Tanner JM, Goldstein H, Whitehouse RH 1970 Standards for children's height at ages 2-9 years allowing for height of parents. Arch Dis Child 47:755-762
18. Greulich WW, Pyle SI 1959 Radiographic atlas of skeletal development of the hand and wrist, 2nd Ed. Stanford: Stanford University Press
19. Working Group on Neonatal Screening of the European Society for Paediatric Endocrinology 2001 Procedure for neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm Res 55:201-205
20. Azziz R, Dewailly D, Owerbach D 1994 Clinical review 56: nonclassical adrenal hyperplasia: current concepts. J Clin Endocrinol Metab 78:810-815
21. L'Allemand D, Tardy V, Gruters A, Schnabel D, Krude H, Morel Y 2000 How a patient homozygous for a 30-kb deletion of the C4-CYP21 genomic region can have a nonclassic form of 21-hydroxylase deficiency. J Clin Endocrinol Metab 85:4562-4567
22. Portrat-Doyen S, Tourniaire J, Richard O, Mulatero P, Aupetit-Faisant B, Curnow KM, Pascoe L, Morel Y 1998 Isolated aldosterone synthase deficiency caused by simultaneous E198D and V386A mutations in the CYP11B2 gene. J Clin Endocrinol Metab 83:4156-4161
23. Morel Y, Andre J, Uring-Lambert B, Hauptmann G, Betuel H, Tossi M, Forest MG, David M, Bertrand J, Miller WL 1989 Rearrangements and point mutations of P450c21 genes are distinguished by five restriction endonuclease haplotypes identified by a new probing strategy in 57 families with congenital adrenal hyperplasia. J Clin Invest 83:527-536
24. Speiser PW, Dupont J, Zhu D, Serrat J, Buegeleisen M, Tusie-Luna MT, Lesser M, New MI, White PC 1992 Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest 90:584-595
25. Nordenström A, Thilen A, Hagenfeldt L, Larsson A, Wedell A 1999 Genotyping is a valuable diagnostic complement to neonatal screening for congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab 84:1505-1509
26. Loke KY, Seng Lee Y, Rhen Lee WW, Seng Poh LK 2001 Molecular analysis of CYP-21 mutations for congenital adrenal hyperplasia in Singapore. Horm Res 55:179-184
27. 356 of human steroid 21-hydroxylase may impair redox partner interaction. Hum Genet 99:704-709
28. Nordenstrôm A, Servin A, Bohlin G, Larsson A, Wedell A 2002 Sex-typed toy play behavior correlates with the degree of prenatal androgen exposure assessed by CYP21 genotype in girls with congenital adrenal hyperplasia. J Clin Endocrinol Metab 87:5119-5124
29. Charmandari E, Hindmarsh P, Johnston A, Brook C 2001 Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: alterations in cortisol pharmacokinetics at puberty. J Clin Endocrinol Metab 86:2701-2708
30. Eugster EA, Dimeglio LA, Wright JC, Freidenberg GR, Seshadri R, Pescovitz OH 2001 Height outcome in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency: a meta-analysis. J Pediatr 138:26-32
31. New MI 2001 Factors determining final height in congenital adrenal hyperplasia. J Pediatr Endocrinol Metab 14:933-937
32. David M, Sempe M, Blanc M 1994 Taille définitive chez 69 sujets atteints d'hyperplasie congénitale des surrénales par déficit en 21-hydroxylase. Arch Pédiatr 1:363-367
33. Cabrera M, Vogiatzi M, New M 2001 Long term outcome in adult males with classic congenital adrenal hyperplasia. J Clin Endocrinol Metab 86:3070-3078
34. Charmandari E, Matthews D, Johnston A, Brook CG, Hindmarsh PC 2001 Serum cortisol and 17-hydroxyprogesterone interrelation in classical 21-hydroxylase deficiency: is current replacement therapy satisfactory? J Clin Endocrinol Metab 86:4679-4685
35. Weintrob N, Dickerman Z, Sprecher E, Galatzer A, Pertzelan A 1997 Non-classical 21-hydroxylase deficiency in infancy and childhood: the effect of time of initiation of therapy on puberty and final height. Eur J Endocrinol 136:188-195
36. Merke DP, Bornstein SR, Avila NA, Chrousos GP 2002 Future directions in the study and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Ann Intern Med 136:320-334
37. Laue L, Merke DP, Jones JV, Barnes KM, Hill S, Cutler GB 1996 A preliminary study of flutamide, testolactone, and reduced hydrocortisone dose in the treatment of congenital adrenal hyperplasia. J Clin Endocrinol Metab 81:3535-3539
38. Van Wyk JJ, Gunther DF, Ritzen EM, Wedell A, Cutler GB, Migeon CJ, New MI 1996 The use of adrenalectomy as treatment for congenital adrenal hyperplasia. J Clin Endocrinol Metab 81:3180-3190
39. Jääskeläinen J, Voutilainen R 2000 Long-term outcome of classical 21-hydroxylase deficiency: diagnosis, complications and quality of life. Acta Paediatr 89:183-187
40. Donaldson M, Thomas P, Love J, Murray G, McNinch A, Savage D 1994 Presentation, acute illness, and learning difficulties in saltwasting 21-hydroxylase deficiency. Arch Dis Child 70:214-218
41. Charmandari E, Lichtarowicz-Krynska EJ, Hindmarsh PC, Johnston A, Aynsley-Green A, Brook CG 2001 Congenital adrenal hyperplasia: management during critical illness. Arch Dis Child 85:26-28
42. Charmandari E, Johnston A, Brook CG, Hindmarsh PC 2001 Bioavaibility of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Endocrinol 169:65-70
43. Ritzen EM, Lajic S, Wedell A 2000 How can molecular biology contribute to the management of congenital adrenal hyperplasia?. Horm Res 53:34-37
44. Clayton PE, Miller WL, Oberfield SE, Ritzen EM, Sippell WG, Speiser PW 2002 Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Pediatric Endocrinology. J Clin Endocrinol Metab 87:4048-4053
45. Morel Y, Tardy V 1997 Molecular genetics of 21-hydroxylase deficient adrenal hyperplasia. In: Azziz R, Nestler JE, Dewailly D, eds. Androgen excess disorders in women. Philadelphia: Lippincott-Raven; 159-162